Up next

Autoplay

Neurology News Network: November 3, 2018

1 Views • 08/28/25
Share
Side Effects
Side Effects
Subscribers
0

This week, Neurology News Network covered the FDA approval of sodium oxybate (Xyrem) oral solution to include pediatric narcolepsy patients aged 7 years and older with cataplexy or excessive daytime sleepiness, the findings from a phase 2a clinical trial of ANAVEX 2-73, an investigational therapy for Alzheimer disease, a conversation with Dr. Richard Lipton about ubrogepant, and an interview with Dr. George Koshy Vilanilam to discuss the findings of a study he conducted to assess the trends and identify the risk factors for patients with migraine of developing ischemic stroke.

Show more
0 Comments sort Sort By

Up next

Autoplay